{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:04:05Z","timestamp":1790370245434,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymgme.2026.110209","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:24:09Z","timestamp":1784042649000},"page":"110209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["L-citrulline treatment of nitric oxide deficiency in MELAS a phase I dose-finding and safety study"],"prefix":"10.1016","volume":"149","author":[{"given":"Mohammed","family":"Almannai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman W.","family":"El-Hattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Bauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Hawk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Soler-Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lacey","family":"Delay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zili D.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charul","family":"Gijavanekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Elsea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Kralik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shing","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Scaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ymgme.2026.110209_bb0005","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.21196","article-title":"Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children","volume":"62","author":"Uusimaa","year":"2007","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110209_bb0010","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000402","article-title":"Mitochondrial diseases in North America: an analysis of the NAMDC registry","volume":"6","author":"Barca","year":"2020","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.ymgme.2026.110209_bb0015","article-title":"Pathogenic mitochondrial DNA 3243A>G mutation: from genetics to phenotype","volume":"13","author":"Li","year":"2022","journal-title":"Front. Genet."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2026.110209_bb0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2015.06.004","article-title":"MELAS syndrome: clinical manifestations, pathogenesis, and treatment options","volume":"116","author":"El-Hattab","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110209_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells1010001","article-title":"Impact of mitochondrial A3243G heteroplasmy on mitochondrial bioenergetics and dynamics of directly reprogrammed MELAS neurons","volume":"12","author":"Lin","year":"2023","journal-title":"Cells"},{"issue":"25","key":"10.1016\/j.ymgme.2026.110209_bb0030","doi-asserted-by":"crossref","first-page":"19198","DOI":"10.1074\/jbc.M908734199","article-title":"The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes*","volume":"275","author":"Chomyn","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110209_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-42262-2","article-title":"Quantitative variation in m.3243A>G mutation produce discrete changes in energy metabolism","volume":"9","author":"McMillan","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110209_bb0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/hmg\/ddu427","article-title":"The ROS-sensitive microRNA-9\/9* controls the expression of mitochondrial tRNA-modifying enzymes and is involved in the molecular mechanism of MELAS syndrome","volume":"24","author":"Meseguer","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2026.110209_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.682780","article-title":"Nitric oxide deficiency in mitochondrial disorders: the utility of arginine and citrulline","volume":"14","author":"Almannai","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymgme.2026.110209_bb0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1196\/annals.1444.011","article-title":"Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome","volume":"1142","author":"Sproule","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110209_bb0055","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1212\/01.WNL.0000151976.60624.01","article-title":"L-arginine improves the symptoms of strokelike episodes in MELAS","volume":"64","author":"Koga","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ymgme.2026.110209_bb0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ymgme.2016.01.010","article-title":"Impaired nitric oxide production in children with MELAS syndrome and the effect of arginine and citrulline supplementation","volume":"117","author":"El-Hattab","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110209_bb0065","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ymgme.2012.01.016","article-title":"Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation","volume":"105","author":"El-Hattab","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"7","key":"10.1016\/j.ymgme.2026.110209_bb0070","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110209_bb0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00726-005-0235-4","article-title":"Almost all about citrulline in mammals","volume":"29","author":"Curis","year":"2005","journal-title":"Amino Acids"},{"issue":"6122","key":"10.1016\/j.ymgme.2026.110209_bb0080","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/327524a0","article-title":"Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor","volume":"327","author":"Palmer","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2026.110209_bb0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jns.2004.11.026","article-title":"Hypocitrullinemia in patients with MELAS: an insight into the \u201cMELAS paradox.\u201d","author":"Naini","year":"2005","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110209_bb0090","article-title":"The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia","volume":"158","author":"P","year":"1999","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2026.110209_bb0095","article-title":"Integrated analysis of the involvement of nitric oxide synthesis in mitochondrial proliferation, mitochondrial deficiency and apoptosis in skeletal muscle fibres","volume":"6","author":"Rodrigues","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ymgme.2026.110209_bb0100","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bbadis.2012.01.010","article-title":"Metabolically induced heteroplasmy shifting and L-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS","volume":"1822","author":"Desquiret-Dumas","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.ymgme.2026.110209_bb0105","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1212\/WNL.58.5.827","article-title":"Effects of L-arginine on the acute phase of strokes in three patients with MELAS","volume":"58","author":"Koga","year":"2002","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ymgme.2026.110209_bb0110","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/01.wnl.0000220197.36849.1e","article-title":"Endothelial dysfunction in MELAS improved by l-arginine supplementation","volume":"66","author":"Koga","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ymgme.2026.110209_bb0115","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1006\/bbrc.2000.3169","article-title":"Regulation of nitric oxide production by arginine metabolic enzymes","volume":"275","author":"Mori","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2026.110209_bb0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mgene.2013.09.001","article-title":"The effect of citrulline and arginine supplementation on lactic acidemia in MELAS syndrome","volume":"5","author":"El-Hattab","year":"2013","journal-title":"Meta Gene."},{"key":"10.1016\/j.ymgme.2026.110209_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-023-02800-8","article-title":"Citrulline in the management of patients with urea cycle disorders","volume":"18","author":"Imbard","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110209_bb0130","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.0006-341X.2000.01177.x","article-title":"Sequential designs for phase I clinical trials with late-onset toxicities","volume":"56","author":"Cheung","year":"2000","journal-title":"Biometrics"},{"issue":"4","key":"10.1016\/j.ymgme.2026.110209_bb0135","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1017\/S0007114507841110","article-title":"Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study","volume":"99","author":"Moinard","year":"2008","journal-title":"Br. J. Nutr."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110209_bb0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/mrm.1910230106","article-title":"Perfusion imaging","volume":"23","author":"Detre","year":"1992","journal-title":"Magn. Reson. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110209_bb0145","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1073\/pnas.89.1.212","article-title":"Magnetic resonance imaging of perfusion using spin inversion of arterial water","volume":"89","author":"Williams","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2026.110209_bb0150","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.neuroimage.2013.07.007","article-title":"Reliable quantification of BOLD fMRI cerebrovascular reactivity despite poor breath-hold performance","volume":"83","author":"Bright","year":"2013","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/j.ymgme.2026.110209_bb0155","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/mrm.24372","article-title":"Comparing model-based and model-free analysis methods for QUASAR arterial spin labeling perfusion quantification","volume":"69","author":"Chappell","year":"2013","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.ymgme.2026.110209_bb0165","doi-asserted-by":"crossref","DOI":"10.1162\/imag_a_00041","article-title":"BASIL: a toolbox for perfusion quantification using arterial spin labelling","volume":"1","author":"Chappell","year":"2023","journal-title":"Imaging Neurosci."},{"key":"10.1016\/j.ymgme.2026.110209_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fradi.2022.929533","article-title":"A beginner\u2019s guide to arterial spin labeling (ASL) image processing","volume":"2","author":"Clement","year":"2022","journal-title":"Front. Radiol."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110209_bb0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/cercor\/bhg087","article-title":"Automatically parcellating the human cerebral cortex","volume":"14","author":"Fischl","year":"2004","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.ymgme.2026.110209_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fninf.2018.00011","article-title":"IClinfMRI software for integrating functional MRI techniques in presurgical mapping and clinical studies","volume":"12","author":"Hsu","year":"2018","journal-title":"Front. Neuroinform."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110209_bb0190","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/000456329503200103","article-title":"Quantitative methods for amino acid analysis in biological fluids","volume":"32","author":"Walker","year":"1995","journal-title":"Ann. Clin. Biochem."},{"issue":"6","key":"10.1016\/j.ymgme.2026.110209_bb0195","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10545-015-9843-7","article-title":"Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism","volume":"38","author":"Miller","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110209_bb0200","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/jalm\/jfz026","article-title":"Precision of a clinical metabolomics profiling platform for use in the identification of inborn errors of metabolism","volume":"5","author":"Ford","year":"2020","journal-title":"J Appl Lab Med."},{"issue":"7","key":"10.1016\/j.ymgme.2026.110209_bb0205","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.14155","article-title":"Comparison of untargeted metabolomic profiling vs traditional metabolic screening to identify inborn errors of metabolism","volume":"4","author":"Liu","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"9","key":"10.1016\/j.ymgme.2026.110209_bb0210","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/s41436-020-0827-0","article-title":"Integrated analysis of metabolomic profiling and exome data supplements sequence variant interpretation, classification, and diagnosis","volume":"22","author":"Alaimo","year":"2020","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110209_bb0215","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/jcbfm.1985.48","article-title":"Normal average value of cerebral blood flow in younger adults is 50 ml\/100 g\/min","volume":"5","author":"Lassen","year":"1985","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110209_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/ima.22986","article-title":"Range and variability of CBF in young adults: PC-MRI and ASL studies","volume":"34","author":"Su","year":"2024","journal-title":"Int. J. Imaging Syst. Technol."},{"issue":"6 Suppl 2","key":"10.1016\/j.ymgme.2026.110209_bb0225","doi-asserted-by":"crossref","first-page":"1693S","DOI":"10.1093\/jn\/137.6.1693S","article-title":"Adverse gastrointestinal effects of arginine and related amino acids","volume":"137","author":"Grimble","year":"2007","journal-title":"J. Nutr."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110209_bb0230","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00394-013-0585-8","article-title":"Long-term dietary L-arginine supplementation increases endothelial nitric oxide synthase and vasoactive intestinal peptide immunoexpression in rat small intestine","volume":"53","author":"Velickovic","year":"2014","journal-title":"Eur. J. Nutr."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110209_bb0235","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006676-200310000-00001","article-title":"Endocrinology: nitric oxide-mediated insulin secretion in response to citrulline in islet beta-cells","volume":"27","author":"Nakata","year":"2003","journal-title":"Pancreas"},{"issue":"6","key":"10.1016\/j.ymgme.2026.110209_bb0240","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1378\/chest.109.6.1550","article-title":"The hypotensive effect of L-arginine is associated with increased expired nitric oxide in humans","volume":"109","author":"Mehta","year":"1996","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ymgme.2026.110209_bb0245","first-page":"10","article-title":"Effects of L-citrulline supplementation on blood pressure: a systematic review and meta-analysis","volume":"9","author":"Barkhidarian","year":"2019","journal-title":"Avicenna J. Phytomed."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110209_bb0250","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000531286","article-title":"Migraine attacks triggered by ingestion of watermelon","volume":"86","author":"Silva-N\u00e9to","year":"2023","journal-title":"Eur. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110209_bb0255","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1525-139X.2009.00577.x","article-title":"Guanidino compounds as uremic (neuro)toxins","volume":"22","author":"De Deyn","year":"2009","journal-title":"Semin. Dial."},{"key":"10.1016\/j.ymgme.2026.110209_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2010.01.012","article-title":"Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemia","author":"Deignan","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.110209_bb0265","article-title":"Long term follow-up in GAMT deficiency \u2013 correlation of therapy regimen, biochemical and in vivo brain proton MR spectroscopy data","volume":"38","author":"Marten","year":"2024","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.110209_bb0270","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neuroimage.2018.03.047","article-title":"Cerebrovascular reactivity (CVR) MRI with CO2 challenge: a technical review","volume":"187","author":"Liu","year":"2019","journal-title":"Neuroimage"},{"key":"10.1016\/j.ymgme.2026.110209_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.643468","article-title":"Cerebrovascular reactivity measurement using magnetic resonance imaging: a systematic review","volume":"12","author":"Sleight","year":"2021","journal-title":"Front. Physiol."},{"issue":"9","key":"10.1016\/j.ymgme.2026.110209_bb0280","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/01.STR.25.9.1873","article-title":"Cerebral hyperemia in MELAS","volume":"25","author":"Gropen","year":"1994","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.ymgme.2026.110209_bb0285","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1212\/01.WNL.0000091888.26232.FE","article-title":"Slowly progressive spread of the stroke-like lesions in MELAS","volume":"61","author":"Iizuka","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ymgme.2026.110209_bb0290","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.braindev.2007.06.008","article-title":"Inappropriate intracranial hemodynamics in the natural course of MELAS","volume":"30","author":"Nishioka","year":"2008","journal-title":"Brain Dev."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110209_bb0295","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.braindev.2012.03.017","article-title":"Perfusion status of the stroke-like lesion at the hyperacute stage in MELAS","volume":"35","author":"Yeh","year":"2013","journal-title":"Brain Dev."},{"key":"10.1016\/j.ymgme.2026.110209_bb0300","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mito.2015.03.002","article-title":"Cerebral hyperperfusion and decreased cerebrovascular reactivity correlate with neurologic disease severity in MELAS","volume":"22","author":"Rodan","year":"2015","journal-title":"Mitochondrion"},{"issue":"9","key":"10.1016\/j.ymgme.2026.110209_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238224","article-title":"L-arginine effects on cerebrovascular reactivity, perfusion and neurovascular coupling in MELAS (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes) syndrome","volume":"15","author":"Rodan","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ymgme.2026.110209_bb0310","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/19714009211002778","article-title":"Cerebral blood flow changes during aging process and in cognitive disorders: a review","volume":"34","author":"Mokhber","year":"2021","journal-title":"Neuroradiol. J."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:39:24Z","timestamp":1790368764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226004920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":60,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1096719226004920"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110209","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"L-citrulline treatment of nitric oxide deficiency in MELAS a phase I dose-finding and safety study","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110209"}}